November 10/Dartmouth, NS/PR Newswire Europe -- Several media outlets published articles last week suggesting that Omega-3 fish oil supplements fail to show positive results for Alzheimer's patients. This reporting by media outlets came after the Journal of the American Medical Association (JAMA) published the study "Docosahexaenoic Acid Supplementation and Cognitive Decline in Alzheimer Disease: A Randomized Trial," where researchers reported that "Supplementation with DHA compared with placebo did not slow the rate of cognitive and functional decline in patients with mild to moderate Alzheimer disease."
Fish oil was not used in the study, and in fact, the study clearly states that the research was performed using algal oil (which contains only DHA, whereas fish oil contains both EPA and DHA). The findings of the study are being inaccurately reported in the media, with ambiguous, misleading headlines and incorrect content.